Genetic Engineering is a transformative biotechnological discipline that involves the deliberate modification of an organism's genetic material using recombinant DNA technology. This process enables scientists to introduce new genetic traits, modify existing ones, or transfer genes between different species, offering unprecedented opportunities to manipulate the characteristics of organisms for various purposes. One of the primary applications of genetic engineering is the production of genetically modified organisms (GMOs) with desirable traits, such as improved crop yield, resistance to pests or diseases, or enhanced nutritional content. By introducing genes encoding specific traits into the genomes of plants or animals, researchers can develop crops with increased productivity, reduced environmental impact, and improved resilience to changing climate conditions, contributing to global food security and agricultural sustainability. In medicine, genetic engineering holds promise for treating genetic disorders, developing novel therapies, and advancing personalized medicine approaches. Gene therapy, for example, involves delivering therapeutic genes into patient cells to correct genetic defects or modulate disease processes, offering potential treatments for conditions such as cystic fibrosis, hemophilia, and certain types of cancer. Additionally, genetic engineering techniques are used to produce recombinant proteins, such as insulin, human growth hormone, and vaccines, for medical applications.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States